Aspen Neuroscience leverages stem cell biology and genomics for Parkinson disease.
We are the leading company providing a personalized cell therapy with the aim to safely turn the clock back on Parkinson’s disease.
We are leveraging our in-house stem cell biology and genomics platform to provide the world’s first autologous induced pluripotent stem cell (iPSC)-derived neuron replacement therapy for Parkinson’s Disease.
Find out about our organization,mission, our leadership team, our board of directors and scientific advisors.
We are developing autologous IPSC-derived cell replacement therapies, including autologous neuron therapies to help treat both idiopathic and genetically linked forms of Parkinson’s disease.